{"id":402926,"date":"2024-10-20T05:03:42","date_gmt":"2024-10-20T05:03:42","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-22-30445135-dc\/"},"modified":"2024-10-26T09:00:35","modified_gmt":"2024-10-26T09:00:35","slug":"bsi-22-30445135-dc","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-22-30445135-dc\/","title":{"rendered":"BSI 22\/30445135 DC"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 4 Considerations for design inputs 4.1 General 4.2 Risk assessment and usability engineering 4.2.1 Risk assessment 4.2.2 Usability engineering 4.3 Determination of the intended demographic population <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 4.4 Considerations for the determination of requirements for the design of medical devices specific to paediatric users 4.4.1 Considerations in relation to risk (risk-based approach to design) 4.4.2 Considerations in relation to human factors <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 4.4.3 Considerations in relation to design attributes <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 4.4.4 Considerations for accompanying documentation 5 Development of the design specification <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 6 Design verification and validation 6.1 General 6.2 Design verification 6.3 Design validation 6.3.1 General 6.3.2 Usability evaluations (also known as usability tests or user studies) <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 6.3.3 Clinical evaluation <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | Annex\u20acA (informative) Additional considerations for the “paediatric population” <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" BS ISO 23217. Injection systems intended for self-administration by paediatric patients. Guidance for design<\/b><\/p>\n |